$NAVB Navidea Biopharmaceuticals Provides Update on European Marketing Authorizati.. http://t.co/xyCdgh7tTq $NAVB believes that the CHMP has found the safety and efficacy data submitted in the MAA for breast cancer and melanoma to be acceptable.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.